Viewing Study NCT04528108



Ignite Creation Date: 2024-05-06 @ 3:07 PM
Last Modification Date: 2024-10-26 @ 1:43 PM
Study NCT ID: NCT04528108
Status: COMPLETED
Last Update Posted: 2022-08-03
First Post: 2020-08-22

Brief Title: Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome
Sponsor: Childrens Hospital of Fudan University
Organization: Childrens Hospital of Fudan University

Study Overview

Official Title: Efficacy Evaluation of Kidney-tonifying and Tune up Chong-Ren Hemostasis Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome a Randomized Controlled Study
Status: COMPLETED
Status Verified Date: 2022-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to conduct a randomized single blind controlled intervention trial to observe the therapeutic effect of kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine periodic therapy for dysfunctional uterine bleeding based on objective Chinese and western medicine evaluation standard
Detailed Description: Dysfunctional uterine bleeding during adolescence is the most common menstrual disorders during adolescence and the age of children suffering from it tended to be lower Its urgent to explore effective ways to alleviate the pain caused by dysfunctional uterine bleeding

In our research 160 children are randomly divided into a Chinese medication periodic therapy group 80 cases and a Gong Xue Ning control group 80 cases Paticipants in Chinese medication periodic therapy group are treated with kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine for 3 months whereas the Gong Xue Ning control group received Gong Xue Ning capsules for 3 months We compare the effect of the two therapies about hemostasis and menstruation regulation and the change of the thickness of endometrium sex hormones Kisspeptin and PAI-1 in blood before and after the treatment in order to make clear the efficacy and the mechanism of the Chinese medicine periodic therapy

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None